Questions About Cancer? 1-800-4-CANCER

Liver Cancer - Featured Clinical Trials

The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:

  • Combining Angiogenesis-Targeted Treatments for Liver Cancer
    (Posted: 05/29/2012) - In this trial, patients with unresectable hepatocellular carcinoma who are ineligible for a liver transplant or other local therapies will be given oral sorafenib at the standard approved dose and intravenous TRC105.
  • Combining Systemic Therapies for Patients with Advanced Liver Cancer
    (Posted: 03/20/2012) - In this phase III trial, patients with unresectable, locally advanced or metastatic primary liver cancer who have good liver function (Child-Pugh score A) will receive sorafenib and be randomly assigned to also receive either doxorubicin or no additional therapy.